Analytical Data
-
Gene name
shf
- Application
-
Alternative Names
(WIF-1-like protein)
-
Species
Drosophila melanogaster
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9W3W5
-
Expression Region
31-456aa
-
Molecular Weight
54.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of SHF (Spleen and Heart Factor) recombinant proteins has gained considerable attention due to their essential roles in developmental biology and cardiovascular health. SHF is a transcription factor critically involved in the development of the heart and the formation of the cardiac cushion, influencing the differentiation and proliferation of cardiac progenitor cells. Aberrant SHF function has been linked to congenital heart defects and other cardiovascular diseases. Researchers are particularly interested in SHF recombinant proteins as they provide valuable insights into the molecular mechanisms underlying cardiac development and disease. By producing SHF in a recombinant form, scientists can conduct functional assays, structural studies, and interaction analyses, thus elucidating the pathways through which SHF regulates gene expression and cell signaling in cardiac tissues. Furthermore, understanding the role of SHF can potentially pave the way for innovative therapeutic strategies for treating heart-related conditions, making it a significant focus in regenerative medicine and developmental biology research.
